글로벌 비강용종 치료 시장 – 2030년까지의 산업 동향 및 예측

비강 용종 치료 시장 분석 및 규모

비강 용종이 발생하기 쉬운 노령 인구가 빠르게 증가하고 천식, 만성 비염, 비강 용종, 알레르기성 비염과 같은 질병의 유병률이 전 세계적으로 증가함에 따라 예측 기간 동안 시장 성장이 가속화될 것으로 예상됩니다. 또한 비강 용종과 같은 무증상 질병을 진단하기 위한 스크리닝이 증가하고 이 질병과 합병증에 대한 인식이 높아짐에 따라 시장 성장의 길이 더욱 열릴 것입니다. 그러나 일부 국가의 낮은 의료 지출은 시장 성장률을 제한할 것으로 예상됩니다. 또한 증가하는 연구 개발 활동과 최소 침습적 수술 치료 및 요법의 개발은 2023년에서 2030년 사이의 예측 기간 동안 이 글로벌 비강 용종 치료 시장 성장에 영향을 미칠 다양한 새로운 기회를 창출할 가능성이 높습니다.

Data Bridge Market Research는 2022년에 2,718.74백만 달러였던 글로벌 비강 용종 치료 시장이 2030년까지 8,243.69백만 달러에 도달할 것으로 예상되며, 2023년에서 2030년까지의 예측 기간 동안 5.6%의 CAGR을 보일 것으로 분석했습니다. "Ethmoidal Polyp"는 이 유형의 비강 용종의 높은 유병률로 인해 글로벌 비강 용종 치료 시장의 유형 세그먼트를 지배합니다. 시장 가치, 성장률, 세분화, 지리적 범위 및 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

비강 용종 치료 시장 범위 및 세분화

시장 정의

비강 용종은 비강 통로 또는 부비동의 안감에서 발생하는 비암성 성장입니다. 부드럽고 통증이 없으며 일반적으로 눈물 모양이나 포도 모양입니다. 비강 용종은 일반적으로 비강 및 부비동 조직의 만성 염증과 관련이 있으며, 종종 만성 비염, 천식, 알레르기 또는 낭포성 섬유증과 같은 상태에서 발생합니다. 비강 용종은 크기가 다양하며 작고 거의 눈에 띄지 않는 것부터 비강 통로와 부비동을 막을 수 있는 더 큰 성장까지 다양합니다. 비강 용종에 대한 치료 옵션에는 코르티코스테로이드( 비강 스프레이 또는 경구), 항히스타민제 또는 항생제와 같은 약물이 포함될 수 있습니다. 어떤 경우에는 용종을 외과적으로 제거해야 할 수도 있습니다.

글로벌 비강용종 치료 시장 동향

운전자

• 전 세계적으로 천식, 만성 비염, 비강 용종 및 알레르기성 비염 유병률 급증

Surging prevalence of increasing prevalence of diseases such as asthma, chronic rhinosinusitis, nasal polyps, and allergic rhinitis all around the globe is one of the major factors responsible for fostering growth in the market value. Growing number of different types of diseases, rising awareness about the diseases are all responsible for boosting the market growth rate. 

• Research and Development Proficiencies

Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the pharmaceutical drugs and various diagnosis methods will further create lucrative market growth opportunities. Research and development proficiencies being conducted for the integration of advanced technologies in the healthcare facilities is also bolstering the market growth rate.

• Growing Investment for Healthcare Facilities

Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.  

Opportunities

• Expansion of the Pharmaceutical Industry

The pharmaceuticals industry is experiencing growth due to various factors, including advancements in device development, increasing investments in research and development, and expanding healthcare infrastructure. This growth directly impacts the global nasal polyps treatment market.

• Government Investments on Healthcare Infrastructure

The increase in the funding by the federal government is set to drive the market growth rate. Moreover, growth and expansion of healthcare industry being driven by both public and private players especially in the developing economies will create lucrative market growth opportunities. Also, high return on investments assured by the research activities will also work in the favor of the market.

Restraints/Challenges

• Rising Competition

The global nasal polyps treatment market is highly competitive, with numerous companies offering a wide range of products. This can make it challenging for new entrants or smaller companies to gain market share and establish a strong presence.

• High Cost associated with Drug Development and Distribution

The cost of drug development and its distribution is very high in the market. Healthcare systems and payers face cost pressures, and there is a growing demand for cost-effective solutions. Manufacturers need to balance the development of innovative implants with affordability to meet market demands.

This global nasal polyps treatment market  report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global  nasal polyps treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In October 2021, Sanofi announced positive results from a Phase 3 trial evaluating Dupixent (dupilumab) in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). The trial demonstrated significant reduction in nasal polyp size and improved nasal congestion and sense of smell
• In September 2021, AstraZeneca announced that the European Commission approved Fasenra (benralizumab) as an add-on maintenance treatment for severe eosinophilic nasal polyps in adult patients

Global Nasal Polyps Treatment Market Scope

The global nasal polyps treatment market is segmented on the basis of type, related diseases, treatment, complication, drug class, diagnosis, treatment, medication, route of administration, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Ethmoidal Polyp
• Antrochoanal Polyp
• Others

Related Diseases

• Chronic Sinusitis
• Cystic Fibrosis (CF)
• Allergic Fungal Sinusitis (AFS)
• Others

Treatment

• Pharmacological Therapies
• Surgeries
• Medication
• Others

Complications

• Obstructive Sleep Apnea
• Sinus Infections
• Others

Drug Class

• Corticosteroids
• Antibiotics
• Leukotriene Inhibitors
• Others

Diagnosis

• Nasal Endoscopy
• Blood Test
• Allergy Tests
• Others

Medication

• Nasal Corticosteroids
• Medication to Treat Nasal Polyps
• Chronic Sinusitis
• Others

Route of Administration

• Oral
• Injectable
• Others

End Users

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• Others

Global Nasal Polyps Treatment Market Regional Analysis/Insights

The global nasal polyps treatment market is analysed and market size insights and trends are provided by country, type, related diseases, treatment, complication, drug class, diagnosis, treatment, medication, route of administration, end user and distribution channel as referenced above.

The countries covered in the global nasal polyps treatment market  report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the global nasal polyps treatment market because of the strong base of healthcare facilities, strong presence of major players in the market, and rising number of research activities in this region.   

Asia-Pacific is expected to witness significant growth in the global nasal polyps treatment market  during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, rise in healthcare facilities, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global nasal polyps treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global nasal polyps treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global nasal polyps treatment market. The data is available for historic period 2015-2020.

Competitive Landscape and Global Nasal Polyps Treatment Market Share Analysis

글로벌 비강 용종 치료 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 글로벌 비강 용종 치료 시장과 관련된 회사의 초점에만 관련이 있습니다.

글로벌 비강 용종 치료 시장에서 활동하는 주요 기업은 다음과 같습니다.

• 애벗(미국)
• 사노피(프랑스)
• 아스트라제네카(영국)
• Teva Pharmaceutical Industries Ltd. (이스라엘)
• 존슨앤존슨 서비스 주식회사(미국)
• 파이저 주식회사(미국)
• Novartis International AG(스위스)
• GSK plc (영국)
• Bayer AG(독일)
• Sun Pharmaceutical Industries Ltd. (인도)
• Cipla Ltd. (인도)
• 마일런 NV(미국)
• 머크 KGaA(독일)

SKU-50414